Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $123.0 million.

  • Pediatrix Medical's Short-term Investments rose 550.59% to $123.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.0 million, marking a year-over-year increase of 550.59%. This contributed to the annual value of $118.6 million for FY2024, which is 1347.66% up from last year.
  • Per Pediatrix Medical's latest filing, its Short-term Investments stood at $123.0 million for Q3 2025, which was up 550.59% from $123.6 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Short-term Investments ranged from a high of $123.6 million in Q2 2025 and a low of $89.6 million during Q1 2022
  • For the 5-year period, Pediatrix Medical's Short-term Investments averaged around $104.9 million, with its median value being $100.8 million (2021).
  • In the last 5 years, Pediatrix Medical's Short-term Investments surged by 2076.15% in 2021 and then tumbled by 1114.46% in 2022.
  • Quarter analysis of 5 years shows Pediatrix Medical's Short-term Investments stood at $99.7 million in 2021, then decreased by 6.49% to $93.2 million in 2022, then grew by 12.06% to $104.5 million in 2023, then grew by 13.48% to $118.6 million in 2024, then rose by 3.78% to $123.0 million in 2025.
  • Its Short-term Investments stands at $123.0 million for Q3 2025, versus $123.6 million for Q2 2025 and $120.2 million for Q1 2025.